Best Microdose Brands 2026

Microdosing is taking sub-perceptual doses (1/10th to 1/20th of a typical full dose) of a psychoactive mushroom product on a regular schedule — typically Paul Stamets' 4-days-on / 3-days-off protocol or James Fadiman's 1-day-on / 2-days-off. Goal: subtle mood, focus, or creativity support without perceptible acute effects. The practice originated with psilocybin but has expanded to include amanita muscaria microdoses and functional mushroom sub-clinical dosing.

1-2mg muscimol per dose — roughly 100-200mg of standardized amanita muscaria extract. That's typically 1/4 to 1/2 of a commercial 'full dose' gummy. Sub-perceptual: you should not feel noticeable acute effects. If you're feeling sedation or body heaviness, you've crossed into a full-dose experience.

0.1-0.3g dried psilocybin mushrooms (or 50-200mg pure psilocybin equivalent in tablet/strip format). Sub-perceptual by design. Note: psilocybin microdoses are legal in the US only where the underlying compound is legal (Oregon therapeutic program, Colorado regulated access). Elsewhere in the US and most of the world, psilocybin microdosing remains federally illegal despite the sub-perceptual dose.

Three legitimacy markers: (1) published muscimol or psilocybin content per unit; (2) Certificate of Analysis (COA) available on request; (3) consistent batch-level dosing (not 'hope for the best' variable strength). Brands meeting all three in the functional/amanita microdose space include Micro Dot, Wunder, Silly Dots, and Road Trip's Day Trip microdose line. Most gas-station microdose brands fail at least one of these marks.

Typical protocols: 4-8 weeks, then take a 2-week tolerance break. Microdosing daily for months on end builds GABA-A or 5-HT2A tolerance depending on the substance and diminishes effects. Cycling protects receptor sensitivity and lets you evaluate whether microdosing is actually producing benefit versus placebo.

Evidence is mixed. Anecdotal reports are strongly positive (users report improved mood, creativity, focus). Placebo-controlled trials — when conducted rigorously — often show effects consistent with placebo response. Meta-analyses suggest genuine small effects on mood and creativity at the population level, but with substantial individual variance. If you microdose, track your subjective response honestly; if no effect after 4 weeks, stop.

Generally yes at sub-perceptual doses, with standard caveats: no combining with SSRIs, benzodiazepines, or other serotonergic/GABAergic drugs; avoid driving for the first few sessions to confirm your subjective threshold; cycle doses to prevent tolerance buildup; always know your substance (unverified microdose products have occasionally contained unexpected compounds including synthetic analogs).